Skip to content
Screener
DexCom logo

DexCom

DXCM

DexCom is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Jacob Steven Leach, with a market cap of $33.6B.

Market cap
$33.57B+12.1%
Revenue$5.0B+15.5%
Net income$999.7M+74.9%
EPS (diluted)$2.52+75.0%
Trailing twelve months · change vs. prior year

Earnings

Q2 2026 report

July 30, 2026
Revenue$1.3BBeat by $18.1MEPS$0.70Beat by $0.09

Next report

Oct 29, 2026 (in 2 months)
Revenue estimate$1.3B
EPS estimate$0.66

Financials

Q2 2026

Income statement

See full
Revenue$1.3B+13.1%
Gross profit$830.0M+20.5%
Operating income$318.3M+49.7%
Net income$249.1M+38.5%
EPS (diluted)$0.64+42.2%

Balance sheet

See full
Cash & equivalents$1.1B-4.8%
Total debt$103.3M-23.1%
Total equity$2.6B+1.9%
Total assets$6.5B-11.9%

Valuation & ratios

Valuation

See full
Market cap$33.57B+12.1%
Enterprise value$32.57B+12.6%
P/E33.6×-18.8×
P/S6.8×-0.2×

Profitability

See full
Gross margin62.5%+3.7pp
Operating margin22.9%+6.9pp
Net margin20.1%+6.8pp

Returns & leverage

See full
Return on equity38.5%+15.7pp
Debt / equity0×0.0×
Current ratio1.7×+0.2×

Profile

CountryUnited States of America
Listed2005
Employees9.6K
CEOJacob Steven Leach
SectorHealthcare
IndustryMedical - Devices
Websitedexcom.com
FilingsSEC EDGAR

FAQ

What is DexCom's market cap?
DexCom (DXCM) has a market capitalization of $33.6B and trades on NASDAQ.
What is DexCom's revenue and profitability?
DexCom generated $5.0B in trailing twelve-month revenue with net income of $999.7M, representing a net margin of 20.1%. Gross margin stands at 62.5%. These figures are based on the Q2 2026 filing.
Where is DexCom headquartered?
DexCom is headquartered in United States of America and employs approximately 9,600 people. It has been publicly traded since 2005.